2.305 USD
0.205
9.76%
Last update Dec 17, 3:07 PM EST
Main market
Day range
2.15
2.4
Previous close
2.100000
Open
2.15
Access this stock data via API
Subscribe
NRX Pharmaceuticals Inc.
2.31
0.21
9.76%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 242K 0 0 0
Cost of revenue 97K
Gross profit 145K
Operating expense
Research & development 1.4M 987K 804K 1.0M
Selling general and admin 2.8M 2.7M 2.9M 2.6M
Other operating expenses -94K
Operating income -4.0M -3.7M -3.7M -2.4M
Non operating interest income
Income 2K 2K 4K 4K
Expense 0 0 0 0
Other income expense -1.9M -13.9M -1.8M -6.7M
Pretax income -5.9M -17.6M -5.5M -9.1M
Tax provision
Net income -5.9M -17.6M -5.5M -9.1M
Basic EPS -0.3 -1.0 -0.3
Diluted EPS -0.3 -1.0 -0.3
Basic average shares 22.2M 17.9M 16.4M
Diluted average shares 22.2M 17.9M 16.4M
EBITDA -5.5M -11.2M -7.0M -7.4M
Net income from continuing op. -5.9M -17.6M -5.5M -9.1M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 50 minutes

15:09
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).